Name: Ubrogepant - API Standards
Brand: Pharmaffliates
Rating: 4.00 (5 reviews)

Catalogue number:	PA 21 0250000
Chemical name:	Ubrogepant
CAS Number:	1374248-77-7
Category:	metabolites,pharmaceutical standards,intermediates,Fine Chemicals
Synonyms:	(S)-N-((3S,5S,6R)-6-Methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide; (3′S)-1′,2′,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide; Ubrelvy;
Molecular form:	C₂₉H₂₆F₃N₅O₃
Appearance:	NA
Mol. Weight:	549.55
Storage:	2-8°C Refrigerator
Shipping Conditions:	Ambient
Applications:	Ubrogepant is an oral CGRP antagonist used in the acute treatment of migraine with or without aura.Ubrogepant is indicated for the acute treatment of migraine headaches with or without aura in adults.5 It was approved by the FDA on December 23, 2019, and is the first oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine.6 Several oral small molecule CGRP receptor antagonists, belonging to a class of medications referred to as "gepants", have been investigated for migraines, but only ubrogepant and rimegepant remain in clinical development

Enquire for Ubrogepant - API Standards

Ubrogepant - API Standards

CAS Number: